Dynavax`s HEPLISAV Shows Increased Protection Rate for Chronic Kidney Disease ... - Reuters |
|
|
ReutersIn 2006, there were approximately 750000 end-stage renal disease (ESRD) patients in the United States and the 5 major European markets and approximately ...
|